Evidence map›Paper›PMID 40193385›Full record

ArticlePLoS genetics2025

PPDPF is not a key regulator of human pancreas development.

Markus Breunig, Meike Hohwieler, Jasmin Haderspeck, Felix von Zweydorf, Natalie Hauff, Lino-Pascal Pasquini, Christoph Wiegreffe, Eleni Zimmer, Medhanie A Mulaw, Cécile Julier and 4 more

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Markus BreunigInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany.ORCID https://orcid.org/0000-0002-2817-1974
Meike HohwielerInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany.ORCID https://orcid.org/0000-0002-0640-0764
Jasmin HaderspeckInstitute of Neuroanatomy & Developmental Biology (INDB), Eberhard Karls University Tübingen, Tübingen, Germany.
Felix von ZweydorfDZNE-German Center for Neurodegenerative Diseases, Tübingen, Germany.
Natalie HauffInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany.
Lino-Pascal PasquiniInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany.ORCID https://orcid.org/0009-0008-9051-3526
Christoph WiegreffeInstitute of Molecular and Cellular Anatomy, Ulm University, Ulm, Germany.
Eleni ZimmerInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany.ORCID https://orcid.org/0000-0002-2510-3140
Medhanie A MulawCentral Unit Single Cell Sequencing, Medical Faculty, Ulm University, Ulm, Germany.
Cécile JulierInstitut Cochin, Inserm U1016-CNRS UMR8104-Université Paris Descartes, Paris, France.ORCID https://orcid.org/0000-0002-1538-0240
Eric SimonCardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
Christian Johannes GloecknerDZNE-German Center for Neurodegenerative Diseases, Tübingen, Germany.
Stefan LiebauInstitute of Neuroanatomy & Developmental Biology (INDB), Eberhard Karls University Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0003-0721-8187
Alexander KlegerInstitute of Molecular Oncology and Stem Cell Biology (IMOS), Ulm University Hospital, Ulm, Germany.ORCID https://orcid.org/0000-0003-0592-5232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given their capability to differentiate into each cell type of the human body, human pluripotent stem cells (hPSCs) provide a unique platform for developmental studies. In the current study, we employed this cell system to understand the role of pancreatic progenitor differentiation and proliferation factor (PPDPF), a protein that has been little explored so far. While the zebrafish orthologue exdpf is essential for exocrine pancreas specification, its importance for mammalian and human development has not been studied yet. We implemented a four times CRISPR/Cas9 nicking approach to knockout PPDPF in human embryonic stem cells (hESCs) and differentiated PPDPFKO/KO and PPDPFWT/WT cells towards the pancreatic lineage. In contrast to data obtained from zebrafish, a very modest effect of the knockout was observed in the development of pancreatic progenitors in vitro, not affecting lineage specification upon orthotopic transplantation in vivo. The modest effect is in line with the finding that genetic variants near PPDPF are associated with random glucose levels in humans, but not with type 2 diabetes risk, supporting that dysregulation of this gene may only result in minor alterations of glycaemic balance in humans. In addition, PPDPF is less organ- and cell type specifically expressed in higher vertebrates and its so far reported functions appear highly context-dependent.

Indexed as

PancreasAnimalsCell DifferentiationCell LineageCRISPR-Cas SystemsGene Expression Regulation, DevelopmentalGene Knockout TechniquesHuman Embryonic Stem CellsHumansPluripotent Stem CellsZebrafish

Identifiers

PMID40193385
PMCPMC12037078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.